<DOC>
	<DOCNO>NCT01977963</DOCNO>
	<brief_summary>Thionamides , antithyroid drug , widely use treat hyperthyroidism1 . Side effect find 1 % - 5 % patients1 . One serious side effect agranulocytosis , occur 0.1 % - 0.3 % patients1 . This might lead severe infection sometimes mortality . The underlie mechanism unclear . An immune phenomenon may involve antigranulocyte antibody lymphocyte sensitize antithyroid drug find patients6,7 . The recognition major histocompatibility complex class II peptide complex T lymphocytes central development immune response . According report 1996 , HLA DRB1*08032 allele strongly associate susceptibility methimazole-induced agranulocytosis20 . Recently , new technique genetics study . We aim identify associate genetic change agranulocytosis side effect antithyroid drug . First , look classical human Leukocyte Antigen ( HLA ) locus , HLA-A , -B , -C , -DR , -DQ -DP . If significant change find gene , consider whole exon sequence next-generation sequencing , Statistic analysis include appropriate linkage analysis , association study , variation data analysis , pathway analysis . If identify genetic change perform genetic examination prescription , avoid happen severe side effect .</brief_summary>
	<brief_title>Genetic Study Antithyroid Drugs Associated Agranulocytosis</brief_title>
	<detailed_description />
	<mesh_term>Agranulocytosis</mesh_term>
	<mesh_term>Antithyroid Agents</mesh_term>
	<criteria>patient absolute neutrophil count lower 500/mm3 cause antithyroid drug Patients young 20 year old old 85 year old</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>